$CBUS
Cibus, Inc.

2020 Q2 Form 10-Q Financial Statement

#000156459020022267 Filed on May 07, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2020 Q1 2019 Q1
Revenue $2.307M $2.377M $157.0K
YoY Change 465.44% 1414.01% 1327.27%
Cost Of Revenue $5.321M $3.884M $34.00K
YoY Change 1656.11% 11323.53%
Gross Profit -$3.014M -$1.507M $123.0K
YoY Change -2970.48% -1325.2% 1018.18%
Gross Profit Margin -130.65% -63.4% 78.34%
Selling, General & Admin $5.167M $6.300M $5.241M
YoY Change -19.37% 20.21% 95.85%
% of Gross Profit 4260.98%
Research & Development $2.825M $2.787M $2.219M
YoY Change 3.18% 25.6% 111.74%
% of Gross Profit 1804.07%
Depreciation & Amortization $450.0K $452.0K $342.0K
YoY Change 28.57% 32.16% 119.23%
% of Gross Profit 278.05%
Operating Expenses $8.034M $9.147M $7.646M
YoY Change -16.29% 19.63% 77.52%
Operating Profit -$11.05M -$10.65M -$7.523M
YoY Change 16.39% 41.62% 75.12%
Interest Expense $371.0K $372.0K $370.0K
YoY Change 0.27% 0.54% 57.45%
% of Operating Profit
Other Income/Expense, Net -$8.000K -$11.00K
YoY Change
Pretax Income -$10.90M -$11.06M -$7.375M
YoY Change 15.94% 50.01% 68.76%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$10.90M -$11.06M -$7.375M
YoY Change 15.94% 50.01% 68.76%
Net Earnings / Revenue -472.56% -465.42% -4697.45%
Basic Earnings Per Share
Diluted Earnings Per Share -$329.9K -$335.3K -$225.8K
COMMON SHARES
Basic Shares Outstanding 33.04M 32.99M 32.69M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q2 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $33.80M $46.00M $84.20M
YoY Change -55.76% -45.37% 66.07%
Cash & Equivalents $3.875M $7.385M $84.23M
Short-Term Investments $29.90M $38.60M
Other Short-Term Assets $2.300M $2.000M $2.200M
YoY Change 21.05% -9.09% 4.76%
Inventory $5.282M $3.198M $379.0K
Prepaid Expenses
Receivables $2.411M $841.0K $124.0K
Other Receivables $0.00 $0.00 $200.0K
Total Short-Term Assets $43.80M $52.03M $87.02M
YoY Change -44.77% -40.21% 64.72%
LONG-TERM ASSETS
Property, Plant & Equipment $22.70M $22.90M $21.85M
YoY Change 0.89% 4.8% 16.45%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.500M $441.0K $674.0K
YoY Change -16.67% -34.57% 149.63%
Total Long-Term Assets $24.20M $24.39M $23.65M
YoY Change -0.41% 3.13% 24.22%
TOTAL ASSETS
Total Short-Term Assets $43.80M $52.03M $87.02M
Total Long-Term Assets $24.20M $24.39M $23.65M
Total Assets $68.00M $76.42M $110.7M
YoY Change -34.36% -30.95% 53.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $600.0K $1.085M $724.0K
YoY Change 50.0% 49.86% 64.17%
Accrued Expenses $3.300M $2.093M $1.610M
YoY Change 3.13% 30.0% 28.18%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $400.0K $400.0K $300.0K
YoY Change 33.33% 33.33%
Total Short-Term Liabilities $4.600M $5.550M $4.650M
YoY Change -8.0% 19.35% 56.46%
LONG-TERM LIABILITIES
Long-Term Debt $1.518M $18.20M $18.20M
YoY Change -91.7% 0.0% 22.97%
Other Long-Term Liabilities $100.0K $141.0K $156.0K
YoY Change -50.0% -9.62% -48.0%
Total Long-Term Liabilities $1.518M $141.0K $156.0K
YoY Change -91.79% -9.62% -98.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.600M $5.550M $4.650M
Total Long-Term Liabilities $1.518M $141.0K $156.0K
Total Liabilities $24.40M $23.89M $22.97M
YoY Change 4.27% 3.99% 27.55%
SHAREHOLDERS EQUITY
Retained Earnings -$144.0M -$133.1M -$89.82M
YoY Change 48.21% 52.45%
Common Stock $186.9M $177.8M
YoY Change 5.12% 57.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $43.55M $52.54M $87.70M
YoY Change
Total Liabilities & Shareholders Equity $67.96M $76.42M $110.7M
YoY Change -34.4% -30.95% 53.99%

Cashflow Statement

Concept 2020 Q2 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income -$10.90M -$11.06M -$7.375M
YoY Change 15.94% 50.01% 68.76%
Depreciation, Depletion And Amortization $450.0K $452.0K $342.0K
YoY Change 28.57% 32.16% 119.23%
Cash From Operating Activities -$13.42M -$12.24M -$9.276M
YoY Change 103.64% 31.93% 41.29%
INVESTING ACTIVITIES
Capital Expenditures -$200.0K $317.0K $346.0K
YoY Change -79.38% -8.38% 743.9%
Acquisitions
YoY Change
Other Investing Activities $8.680M -$38.62M $0.00
YoY Change
Cash From Investing Activities $8.480M -$38.94M -$346.0K
YoY Change -974.23% 11153.47% 743.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.440M -45.00K 66.00K
YoY Change -726.09% -168.18% -89.77%
NET CHANGE
Cash From Operating Activities -13.42M -12.24M -9.276M
Cash From Investing Activities 8.480M -38.94M -346.0K
Cash From Financing Activities 1.440M -45.00K 66.00K
Net Change In Cash -3.500M -51.22M -9.556M
YoY Change -55.07% 436.0% 60.31%
FREE CASH FLOW
Cash From Operating Activities -$13.42M -$12.24M -$9.276M
Capital Expenditures -$200.0K $317.0K $346.0K
Free Cash Flow -$13.22M -$12.56M -$9.622M
YoY Change 135.23% 30.48% 45.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
683-2807
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
185588000
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001705843
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
CALYXT, INC.
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Entity File Number
EntityFileNumber
001-38161
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2020Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1580000
CY2019Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
904000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4720000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4162000
CY2020Q1 clxt Management Fees
ManagementFees
62000
CY2019Q1 clxt Management Fees
ManagementFees
361000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
9149000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
7646000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-10656000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7523000
CY2020Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-398000
CY2019Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
172000
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-9000
CY2019Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-24000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11063000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7375000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-11063000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-7375000
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
32988141
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
32677944
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
3000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
324000
CY2020Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1043000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-133120000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-163000
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
141000
CY2020Q1 us-gaap Liabilities
Liabilities
23885000
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
186859000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
441000
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1594000
CY2019Q4 us-gaap Assets
Assets
88098000
CY2019Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2181000
CY2020Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
361000
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2093000
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
CY2020Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
554000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7385000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
52033000
CY2020Q1 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
1045000
CY2020Q1 us-gaap Short Term Investments
ShortTermInvestments
38620000
CY2019Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
1040000
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2019Q4 us-gaap Assets Current
AssetsCurrent
63522000
CY2019Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
977000
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1967997
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2020Q1 us-gaap Assets
Assets
76421000
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
356000
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
94000
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
61000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5550000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22902000
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1085000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1122000
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Roseville
CY2020Q1 us-gaap Inventory Net
InventoryNet
3198000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1077000
CY2019Q4 us-gaap Inventory Net
InventoryNet
2594000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58610000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2544000
CY2020Q1 dei Security12b Title
Security12bTitle
Common Stock (0.0001 par value)
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23212000
CY2019Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
388000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
808000
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55113-1127
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7196000
CY2020Q1 dei City Area Code
CityAreaCode
651
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33040520
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2800 Mount Ridge Road
CY2019Q1 us-gaap Gross Profit
GrossProfit
123000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
76421000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
34000
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32951329
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33090799
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
18244000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
157000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33033689
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3884000
CY2020Q1 us-gaap Gross Profit
GrossProfit
-1507000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
52536000
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32990647
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2787000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2219000
CY2020Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
100152
CY2019Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
82360
CY2020Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
18194000
CY2020Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
388000
CY2020Q1 dei Trading Symbol
TradingSymbol
CLXT
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1556000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1271000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2377000
CY2020Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
47438000
CY2019Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
85732000
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
841000
CY2020Q1 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
7000
CY2020Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1363000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
150000
CY2019Q4 us-gaap Liabilities
Liabilities
25590000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-180000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
93397000
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
125000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
87703000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-11063000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-7375000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
452000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
342000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1271000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1556000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-281000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
124000
CY2020Q1 clxt Increase Decrease In Due To From Related Parties Current
IncreaseDecreaseInDueToFromRelatedPartiesCurrent
-430000
CY2019Q1 clxt Increase Decrease In Due To From Related Parties Current
IncreaseDecreaseInDueToFromRelatedPartiesCurrent
-1114000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
604000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
379000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
786000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
629000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-94000
CY2020Q1 clxt Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
-451000
CY2019Q1 clxt Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
-397000
CY2020Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-818000
CY2019Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-418000
CY2020Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-156000
CY2019Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-428000
CY2020Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
120000
CY2019Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
216000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12416000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9276000
CY2020Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
38620000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
139000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
346000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-38759000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-346000
CY2020Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
45000
CY2019Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
59000
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
125000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-45000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
66000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-51220000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9556000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60038000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
95288000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8818000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
85732000
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
272000
CY2020Q1 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
39223000
CY2020Q1 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
15509000
CY2019Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
62000
CY2019Q4 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
15651000
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5328268
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4385595
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1976394
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1789567
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1890357
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.73
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.97
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4481359
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
60000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
235894
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4305465
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.73
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.30
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
15.61
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.46
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
353000
CY2020Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
10600000
CY2020Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
24000
CY2019Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
49000
CY2020Q1 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
9200000
CY2020Q1 us-gaap Description Of Defined Contribution Pension And Other Postretirement Plans
DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans
We provide a 401(k) defined contribution plan for all regular full-time employees who have completed three months of service.
CY2020Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
120000
CY2019Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
56000
CY2020Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
2535000
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2211000
CY2020Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
445000
CY2020Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
218000
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
111000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1271000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1590000
CY2020Q1 us-gaap Interest Expense
InterestExpense
372000
CY2019Q1 us-gaap Interest Expense
InterestExpense
370000
CY2020Q1 us-gaap Investment Income Net
InvestmentIncomeNet
-26000
CY2019Q1 us-gaap Investment Income Net
InvestmentIncomeNet
542000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
84231000
CY2020Q1 us-gaap Restricted Cash
RestrictedCash
1433000
CY2019Q1 us-gaap Restricted Cash
RestrictedCash
1501000
CY2020Q1 us-gaap Interest Paid
InterestPaid
367000
CY2019Q1 us-gaap Interest Paid
InterestPaid
365000
CY2020Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1

Files In Submission

Name View Source Status
0001564590-20-022267-index-headers.html Edgar Link pending
0001564590-20-022267-index.html Edgar Link pending
0001564590-20-022267.txt Edgar Link pending
0001564590-20-022267-xbrl.zip Edgar Link pending
clxt-10q_20200331.htm Edgar Link pending
clxt-20200331.xml Edgar Link completed
clxt-20200331.xsd Edgar Link pending
clxt-20200331_cal.xml Edgar Link unprocessable
clxt-20200331_def.xml Edgar Link unprocessable
clxt-20200331_lab.xml Edgar Link unprocessable
clxt-20200331_pre.xml Edgar Link unprocessable
clxt-ex311_8.htm Edgar Link pending
clxt-ex312_7.htm Edgar Link pending
clxt-ex32_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gbc4qp1uipfz000001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending